| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 31-Mar-09 | 26-Dec-08 | | Total Revenue | 18,442 | 21,738 | 23,411 | 28,205 | | Cost of Revenue | 10,279 | 11,635 | 13,204 | 17,062 | | | Gross Profit | 8,163 | 10,103 | 10,207 | 11,143 | | | Operating Expenses | | Research Development | 7,195 | 7,554 | 8,382 | 7,781 | | Selling General and Administrative | 7,926 | 6,635 | 7,357 | 9,388 | | Non Recurring | (92) | 149 | 18,870 | 930 | | Others | 325 | 325 | 325 | 325 | | | | Total Operating Expenses | 15,354 | 14,663 | 34,934 | 18,424 | | | | Operating Income or Loss | (7,191) | (4,560) | (24,727) | (7,281) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,364 | 2,647 | 5,930 | 3,574 | | Earnings Before Interest And Taxes | (4,827) | (1,913) | (18,797) | (3,707) | | Interest Expense | 1 | 4 | (230) | 142 | | Income Before Tax | (4,828) | (1,917) | (18,567) | (3,849) | | Income Tax Expense | (737) | (2,071) | (1,236) | (3,939) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,091) | 154 | (17,331) | 90 | | | Non-recurring Events | | Discontinued Operations | 318 | 440 | 122 | (1,396) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,773) | 594 | (17,209) | (1,306) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,773) | $594 | ($17,209) | ($1,306) |
|
0.11% Nasdaq 0.00%
Income Statement
